Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

deLIVER: Direct Acting Antiviral Effects on the Liver

NCT02938013 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02938013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02938013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
deLIVER: Direct Acting Antiviral Effects on the Liver
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2017
Completion date
September 30, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcv coinfection, hiv, liver disease